Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma

References

• PengCCBurkeMTCarbiaBEPlummerCChauhanAExtended drug delivery by contact lenses for glaucoma therapyJ Control Release2012162115215822721817
   PubMed Web of Science ®Google Scholar
• KatiyarSPanditJMondalRSIn situ gelling dorzolamide loaded chitosan nanoparticles for the treatment of glaucomaCarbohydr Polym201410211712424507263
   PubMed Web of Science ®Google Scholar
• JungHJAbou-JaoudeMCarbiaBEPlummerCChauhanAGlaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lensesJ Control Release20131651828923123188
   PubMed Web of Science ®Google Scholar
• HuangWZhangNHuaHPreparation, pharmacokinetics and pharmacodynamics of ophthalmic thermosensitive in situ hydrogel of betaxolol hydrochlorideBiomed Pharmacother20168310711327470557
   PubMed Web of Science ®Google Scholar
• ChhonkerYSPrasadYDChandasanaHAmphotericin-B entrapped lecithin/chitosan nanoparticles for prolonged ocular applicationInt J Biol Macromol2015721451145825453292
   PubMed Web of Science ®Google Scholar
• LeonardiABucoloCDragoFSalomoneSPignatelloRCationic solid lipid nanoparticles enhance ocular hypotensive effect of melatonin in rabbitInt J Pharm2015478118018625448580
   PubMed Web of Science ®Google Scholar
• BaigMSAhadAAslamMImamSSAqilMAliAApplication of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: optimization, in vitro release, ocular tolerance, and antibacterial activityInt J Biol Macrom201685258270
   PubMed Web of Science ®Google Scholar
• DillenKVandervoortJVan den MooterGLudwigAEvaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticlesInt J Pharm20063141728216600538
   PubMed Web of Science ®Google Scholar
• Ustundag-OkurNGokceEHBozbiyikDIEgrilmezSOzerOErtanGPreparation and in vitro-in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitisEur J Pharm Sci20146320421525111119
   PubMed Web of Science ®Google Scholar
• BattagliaLSerpeLFogliettaFApplication of lipid nanoparticles to ocular drug deliveryExpert Opin Drug Deliv201613121743175727291069
   PubMed Web of Science ®Google Scholar
• GiarmoukakisALabirisGSideroudiHBiodegradable nanoparticles for controlled subconjunctival delivery of latanoprost acid: in vitro and in vivo evaluation. Preliminary resultsExp Eye Res2013112293623603320
   PubMed Web of Science ®Google Scholar
• FangueiroJFAndreaniTEgeaMADesign of cationic lipid nanoparticles for ocular delivery: development, characterization and cytotoxicityInt J Pharm20144611–2647324275449
   PubMedGoogle Scholar
• ParkCGKimYKKimMJMucoadhesive microparticles with a nanostructured surface for enhanced bioavailability of glaucoma drugJ Control Release2015220Pt A18018826478018
   PubMedGoogle Scholar
• AgnihotriSAAminabhaviTMChitosan nanoparticles for prolonged delivery of timolol maleateDrug Dev Ind Pharm200733111254126218058322
   PubMed Web of Science ®Google Scholar
• GoyalRMacriLKKaplanHMKohnJNanoparticles and nanofibers for topical drug deliveryJ Control Release2016240779226518723
   PubMed Web of Science ®Google Scholar
• ChoISParkCGHuhBKThermosensitive hexanoyl glycol chitosan-based ocular delivery system for glaucoma therapyActa Biomater20163912413227163401
   PubMed Web of Science ®Google Scholar
• de la FuenteMRavinaMPaolicelliPSanchezASeijoBAlonsoMJChitosan-based nanostructures: a delivery platform for ocular therapeuticsAdv Drug Deliv Rev201062110011719958805
   PubMed Web of Science ®Google Scholar
• JoshiGVPatelHAKevadiyaBDBajajHCMontmorillonite intercalated with vitamin B1 as drug carrierAppl Clay Sci2009454248253
   Web of Science ®Google Scholar
• LinFHChenCHChengWTKuoTFModified montmorillonite as vector for gene deliveryBiomaterials200627173333333816488006
   PubMed Web of Science ®Google Scholar
• OliveiraASAlcantaraACSPergherSBCBionanocomposite systems based on montmorillonite and biopolymers for the controlled release of olanzapineMater Sci Eng C Mater Biol Appl2017751250125828415414
   PubMed Web of Science ®Google Scholar
• RajkumarSKevadiyaBDBajajHCMontmorillonite/poly (L-lactide) microcomposite spheres as reservoirs of antidepressant drugs and their controlled release propertyAsian J Pharm Sci2015105452458
   Web of Science ®Google Scholar
• LinFHLeeYHJianCHWongJMShiehMJWangCYA study of purified montmorillonite intercalated with 5-fluorouracil as drug carrierBiomaterials2002231981198711996039
   PubMed Web of Science ®Google Scholar
• ZhengJPLuanLWangHYXiLFYaoKDStudy on ibuprofen/montmorillonite intercalation composites as drug release systemAppl Clay Sci2007364297301
   Web of Science ®Google Scholar
• ZhengJShanJFanZYaoKPreparation and properties of gelatin-chitosan/montmorillonite drug-loaded microspheresJ Wuhan Univ Technol Mater Sci Ed2011264628633
   Web of Science ®Google Scholar
• HouDHuSHuangYPreparation and in vitro study of lipid nanoparticles encapsulating drug loaded montmorillonite for ocular deliveryAppl Clay Sci2016119277283
   Web of Science ®Google Scholar
• HuangYTaoQHouDZA novel ion exchange carrier based upon liposome-incorporated montmorillonite for ophthalmic delivery of betaxolol hydrochlorideInt J Nanomed201712115
   PubMed Web of Science ®Google Scholar
• HouDXieCHuangKZhuCThe production and characteristics of solid lipid nanoparticles (SLNs)Biomaterials200324101781178512593960
   PubMed Web of Science ®Google Scholar
• SharmaKSomavarapuSColombaniAGovindNTaylorKMCross-linked chitosan nanoparticle formulations for delivery from pressurized metered dose inhalersEur J Pharm Biopharm2012811748122245573
   PubMed Web of Science ®Google Scholar
• AmeeduzzafarAliJBhatnagarAKumarNAliAChitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbitsInt J Biol Macromol20146547949124530326
   PubMed Web of Science ®Google Scholar
• HouDZGuiRYHuSHuangYPanYFSongFLMethod for preparing novel drug delivery system for encapsulating montmorillonite loaded with chitosanCN104491867A2014
   Google Scholar
• GiannolaLIde CaroVGiandaliaGSiragusaMGCordoneLOcular gelling microspheres: in vitro precorneal retention time and drug permeation through reconstituted corneal epitheliumJ Ocul Pharmacol Ther200824218619618355132
   PubMed Web of Science ®Google Scholar
• ChandasanaHPrasadYDChhonkerYSCorneal targeted nanoparticles for sustained natamycin delivery and their PK/PD indices: an approach to reduce dose and dosing frequencyInt J Pharm20144771–231732525455776
   PubMedGoogle Scholar
• WeiGDingPTZhengJMLuWYPharmacokinetics of timolol in aqueous humor sampled by microdialysis after topical administration of thermosetting gelsBiomed Chromatogr2006201677115954162
   PubMed Web of Science ®Google Scholar
• GanLHanSShenJSelf-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: improving preocular retention and ocular bioavailabilityInt J Pharm20103961–217918720558263
   PubMed Web of Science ®Google Scholar
• LiuRWangSFangSLiquid crystalline nanoparticles as an ophthalmic delivery system for tetrandrine: development, characterization, and in vitro and in vivo evaluationNanoscale Res Lett201611125427188974
   PubMedGoogle Scholar
• TalukderRFassihiRGastroretentive delivery systems: hollow beadsDrug Dev Ind Pharm200430440541215132183
   PubMed Web of Science ®Google Scholar
• WadhwaSPaliwalRPaliwalSRVyasSChitosan and its role in ocular therapeuticsMini Rev Med Chem20099141639164720105127
   PubMed Web of Science ®Google Scholar
• BaşaranEYazanYOcular application of chitosanExpert Opin Drug Deliv20129670171222530690
   PubMed Web of Science ®Google Scholar
• SilvaMMCaladoRMartoJBettencourtAAlmeidaAJGonçalvesLMDChitosan nanoparticles as a mucoadhesive drug delivery system for ocular administrationMar Drugs20171512370
   PubMed Web of Science ®Google Scholar
• HaginoSItagakiHKatoSKobayashiTTanakaMQuantitative evaluation to predict the eye irritancy of chemicals: modification of chorioallantoic membrane test by using trypan blueToxicol In Vitro19915430130420732030
   PubMed Web of Science ®Google Scholar
• LagartoAVegaRGuerraIGonzalezRIn vitro quantitative determination of ophthalmic irritancy by the chorioallantoic membrane test with trypan blue staining as alternative to eye irritation testToxicol In Vitro200620569970216309878
   PubMed Web of Science ®Google Scholar
• NagarwalRCKumarRPanditJKChitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eyeEur J Pharm Sci201247467868522922098
   PubMed Web of Science ®Google Scholar
• PlagerDAWhitsonJTNetlandPABetaxolol hydrochloride ophthalmic suspension 0.25% and timolol gel-forming solution 0.25% and 0.5% in pediatric glaucoma: a randomized clinical trialJ AAPOS20091338439019683191
   PubMed Web of Science ®Google Scholar